Boots is to begin offering private medical cannabis prescriptions through a new specialist service called Sureleaf, in what is described as a first for a high street pharmacy chain in the UK. The move was reported by The Independent and the Daily Express on 16 November 2026.
The service, run through Boots Online Doctor, is aimed at patients with chronic pain, generalised anxiety disorder and insomnia disorder. The reports differ on the minimum age: The Independent says patients must be older than 24, while the Daily Express says over-25s, which amount to the same thing.
How the service works
Patients must first have tried conventional treatments without getting relief from their symptoms. They are assessed online, then have a video consultation with a clinician on the General Medical Council Specialist Register. According to the Daily Express, they are also screened for a history of psychosis or other conditions that would rule out treatment.
The Independent reports that proposed prescriptions will be independently reviewed by a clinical team. Patients who are prescribed treatment will receive ongoing support and monitoring to help judge whether it is working.
The Daily Express reports that cannabis flower or oil could be prescribed for 28-day periods, with the lowest dose costing just under £40.
The chronic pain conditions listed as eligible include chronic primary and neuropathic pain, fibromyalgia, complex regional pain syndrome, chronic back or neck pain, osteoarthritis, rheumatoid arthritis, sciatica, peripheral neuropathy, trigeminal neuralgia, phantom limb pain, chronic migraine, endometriosis-related pelvic pain and chronic abdominal or pancreatic pain.
Research and company comments
Boots is launching the service alongside a research programme with the University of Nottingham, which will look at outcomes for patients prescribed medical cannabis for chronic pain.
Dr David Gwynne, medical director at Boots Online Doctor, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.” He said the service had been designed with “strong clinical safeguards and specialist oversight at every stage”.
Jamie Kerruish, chief healthcare officer for Boots, said the company was committed to making healthcare more accessible. He said millions of people live with ongoing pain and that for some, conventional treatments do not provide adequate relief. Sureleaf, he said, gives eligible patients “another treatment option to consider”.
Background
Specialist doctors in the UK have been able to prescribe cannabis-based medicines since November 2018. A small number of patients receive them on the NHS, but most products are prescribed by private clinics. Cannabis remains a Class B drug under the Misuse of Drugs Act 1971 outside of lawful prescription.
The Independent reports that nearly two million unlicensed cannabis items were prescribed privately in England between June 2025 and May 2026. That growth has prompted warnings about risks to patients and calls for new safeguards for people buying medical cannabis through online platforms.
The Daily Express notes that the launch follows the acquisition of Boots by the Canadian firm Whittington Investments in early October. Neither report links the two developments directly.

Join the conversation
1 comment
Would you feel comfortable getting a private medical cannabis prescription from a high street pharmacy like Boots? Why or why not?
ohhh condoms and weed in the same spot - awesome!